The manuscript by Cavellini, et al., describes relationships between Ubp2 (a deubiquitinating enzyme), Fzo1 (a mitofusin), and two ubiquitin ligases (Mdm30 and Rsp5). Many of the central conclusions are poorly substantiated and there is a lack of molecular understanding of several of the key observations. Given this, the contribution of the work to the field appears to be minimal. Also, the manuscript is in need of extensive editing. The meaning of several key statements is nearly completely lost due to poor sentence structure and word choice.
Page 11, lines 8-12: The conclusions made in the last two sentences of this paragraph are vague and confusing. "Convey" is a poor word choice -should this be replaced by suggest/imply, or demonstrates/indicates? The last sentence of the paragraph is worse, as I am unclear what the evidence is that Mdm30 affects the myriad activities of Rsp5. Figure 4c (mitochondrial fusion assay): It is entirely unclear why the authors found it surprising that there was total co-localization of fluorophores in the rsp5-delta strain. There are absolutely no controls for this experiment -just one highly engineered experimental strain was examined (rsp5-delta expressing Spt23 "p90").
Reviewer #2 (Remarks to the Author) Herein, Cavellini and colleagues describe the antagonistic effects of the deubiquitylase enzyme Ubp2 and of the ubiquitin ligase Mdm30 on the mitofusin Fzo1 in yeast and on mitochondrial function. While Ubp2 deletion destabilizes Fzo1, Mdm30 deletion stabilizes it. They then describe an interesting cross talk between the Ole1 pathway of lipid desaturation (in which Ubp2 plays a role) and mitochondrial fission, indicating that Fzo1 levels must be tightly regulated in the face of fluctuations in lipid saturation.
The study is original, unexpected and interesting. The data are in general of excellent quality and support the most important conclusions of the study. It is a bit unfortunate that the authors did not go as far as testing that the various treatments indeed affect mitochondrial lipid composition as expected, but this is not crucial at this point. Some additional work and some rewriting could nevertheless improve the manuscript.
Here are the points that need to be adressed experimentally: -An important conclusion reached by the authors is that Ubp2 antagonizes Mdm30 by directly removing the K48-linked ubiquitins added by Mdm30. To show this, they use a in vitro deubiquitination assay with recombinant Ubp2 and 5x ubiquitin as a substrate. They observe that Ubp2 can remove one ubiquitin and thus conclude that, contrary to previous knowledge, Ubp2 can hydrolyze K48 bonds provided that the chain is at least 5 Ubiquitin long. The specificity of the reaction is not very well controlled: basically the authors rely on the redox sensitivity of Ubp2 to conclude that the cleavage is indeed performed by Ubp2, and not by a contaminating protease. To confirm the "minimum 5 Ub" models, the authors should repeat the experiments of figure 2C with longer UB chains (several groups have use k48-linked hexa-ubiquitin, it should thus be commercially available). This should lead to the appearance of Ub5 and Ub4 species. This is important to show that Ub5 is indeed the limit and that the removal of one ubiquitin from the Ub5 observed here is not simply a spurious phenomenon.
-The in vitro fusion assays are very tricky. Mitochondria can stick to each other without fusing. Light microscopy will not make any difference, and lipid composition is likely to affect the stickiness of mitochondria. Mitochondrial fusion is however completely blocked by either GMPPNP or CCCP. It is thus worth adding this control to increase the confidence that what is measured here is indeed fusion and not mere stickiness.
-It would be good to have highe exposure panels of all Fzo1 blots, in order to see the ubiquitilated species.
Here are some points that need to be soften or rewritten: -Because Mdm30 is needed to observe the polyubiquitylated forms of Fzo1 (that are substrates for Ubp2), the author concludes that Mdm30 is directly responsible for generating them. An alternative model is that Mdm30-mediated K48-linked oligoubiquitzlation of Fzo1 serves as a signal for the recruitment of a yet-unknown E3-ligase that is going to K63-polyubiquitilate Fzo1, thus generating ubiquitin forms that are substrates of Ubp2. This model is slightly more complicated than that of the authors, but cannot be excluded here. Thus softer wording and acknowledgement of alternative models is required here.
-The coIP experiment is not well explained at all. F-box is not defined in the main text. Is interaction only observable with an f-box mutant? What happens with the WT protein? Why are the same panels used in the supplement and the main figure? -"Since mitochondria are separated from each other in vitro, this spatio-temporal regulation may not be recapitulated, unless Fzo1 levels get increased further". This is a bizarre argument that I cannot understand. Fzo1 levels are naturally increased in oleate-treated yeast. Why should Fzo1 levels be increased further? Mitochndria are not "separated" since they are concentrated by centrifugation.
-"This specific increase in mitofusin levels upon treatment with UFAs was accompanied by decreased detection of the doublet characteristic of Fzo1 ubiquitylation by Mdm30 ( Fig. 5d ; Fzo1-Ub), which is in agreement with the down-regulation of Mdm30-mediated turnover of Fzo1 by stabilized Ubp2 (Fig. 5b) ." This argument appears to contradict everything that has been said and shown before. Ubp2 stabilization should have no effect whatsoever on the short-Ub chain doublet since Ubp2 is said not to act only on long Ub chains.
-The model is that Fzo1 levels are regulated to match lipid instauration levels. In that case deleting Mga2 (thus decreasing insaturation) should lead to decreased Fzo1 levels. Is it the case ? (it may look like it in figure 7G, but that should require repetition and quantification). What is the interpretation if it is not the case? It would be good to see higher exposures of these blots so as to be able to see the ubiquitylated products of Fzo1.
-In general, many sentences could be simplified. e.g. "Absence of the Mdm30 ubiquitin ligase would therefore not restrict to promoting accumulation of mitofusins but may also affect the myriad of functions regulated by the Rsp5/Ubp2 complex." "These results confirm the specific effect of Mdm30 on Ubp2 over dysfunctional mitochondria and suggest Ubp2 modification by the Mdm30 ubiquitin-ligase."
Reviewer #3 (Remarks to the Author) This study addresses the functional interplay of the deubiquitinase (DUB) Ubp2 with ubiquitin ligases, Mdm30 and Rsp5. In the first part of the manuscript the authors report that Ubp2 acts as an antagonist for Mdm30-mediated turnover of Fzo1 and that Mdm30 targets Ubp2 for degradation. Only the latter represents a truly novel finding. The Mdm30-dependent reduction of Ubp2 levels promotes Rsp5-dependent induction of Ole1-dependent desaturation of fatty acids. Lack of Mdm30 impairs Ole1-dependent synthesis of desaturated fatty acids. Interestingly, desaturated fatty acids impair degradation of Ubp2 and thereby stabilize Fzo1 and promote mitochondrial fusion. This second part of the manuscript thus reports on the novel link between mitochondrial fusion and fatty acid desaturation which, in my eyes, is a main and highly relevant finding. Overall, the manuscript is well written and the conclusions are largely justified. Still, some experiments are merely confirmatory or have critical problems as they lack important controls or are not clearly explained. Alternative explanations need to be discussed as well. These points need to be resolved before the manuscript is recommended for publication. Major points: 1. The fact that Ubp2 has an influence on the level/turnover of Fzo1 is already known (Anton et al 2013) . The novelty is more about the antagonism to Mdm30. The confirmatory nature and the novel aspect must be made clearer. 2. The authors show that overexpression of Rsp5 rescues defects caused by lack of Mdm30 and conclude that "accumulation of Ubp2 induces downregulation of Rsp5-mediated functions...". This a possibility but an alternative explanation is that Rsp5 is directly affected by Mdm30. Figure 4a suggests that Rsp5 levels are slightly reduced by loss of Mdm30. Thus, Rsp5-mediated functions are not necessarily affected via Ubp2. The authors should determine whether Mdm30 affects the Rsp5/Ubp2 pathway directly by affecting Rsp5 as well. The authors could test the turnover (CHX chase) of Rsp5 in delta Mdm30. 3. Page 17/18: The rationale for the last part of the results section is not fully clear to me. Why is decreased desaturation and increased turnover of Fzo1 hypothesized to promote fusion? Moreover, the authors state that introduction of an extra copy of Fzo1 induced recue of glycerol growth and tubular mitochondrial morphology in delta ubp2 and double mutants (delta ubp2 delta mga2). Mitochondrial morphology is, however, not recued at all (Fig. 7de) . This needs to be tested statistically to make such a claim. In lines 22/23 the authors mention "increased levels of mitofusins". This is not observed making this conclusion/sentence unclear to me. In general, the authors suggest that the turnover of Fzo1 rather than the level is critical for mitochondrial fusion (and balance of UFAs). The author neglect the possibility that decreased amounts of desaturated fatty acids are the main problem and that Fzo1 may simply need desaturated fatty acids for fusion ( which implies that UFAs are upstream of Fzo1 turnover). 4. The authors must improve the clarity and the proper labelling of several figures. Several experiments also lack loading controls and/or statistical testing. For specific points see below. Minor points: 1. Anton et al 2013 reports on Ubp2-dependent species of ubiquitylated Fzo1 that are low in molecular weight (using expression of an inactive variant of Ubp2). These species are not resolved here (e.g. Fig 2b) . It would be interesting to see whether these species also do depend on Mdm30 (in addition to the "smear" at high MW). 2. The accumulation of high MW ubiquitylated Fzo1 species in delta Ubp2 are not fully convincing. For Fig. 1c a quantification (n>=3 experiments) and a loading control is needed. 3. Fig 1d: Are the differences in Fzo1 turnover really significant? Please include statistical tested significance values in Fig 1d. 4. Correct "Page xx on 47" to "Page xx of 47" 5. Page 4 /line 18: "unexplained" is not correct as models exist. Better: "not fully understood". 6. Page 6 / line 18: Explain better why the expression of Spt23 p90 is needed. The strain must not be labeled as delta strain in the figures as the delta is inviable. 7. Page 10 / line 19: "mitochondrial deficiency" is not correct! Respiratory deficiency? 8. Page 11 / line 22: It is not clear why this should be the "sole candidate". I suggest to rephrase this. 9. Page 13 / line 15: "endogenous" is not correct as it is Ubp2-HA. 10. Figure 2b and 2c: Loading controls are missing. 11. In Figure 2d WT and ubp2Δ Fzo1-Ub banding pattern seems to be different to earlier results (doublet is not clearly seen and high MW species are not enhanced when loading control is taken into account). The immunoblotting is not really convincing. This should be improved. What is the role of K464 residue? Is there an effect in the ubp2Δ strain with K464R, or K398RK464R? 12. For the double mutation of Ubp2 and Mdm30 a confirmation including a rescue of the growth defect would be needed. Also a rescue of the growth defect with a plasmid encoding Mdm30 is missing. The labeling of Figure 3c and 3e are unclear/incomplete also the appropriate size of the bands are missing. The authors should indicate that they show that the DUB bind to Mdm30 f-box mutant NOT to Mdm30 WT (as implied here). 13. Figure 4c : Was the quantification of number of zygotes only performed once? Error bars are missing and/or the number of cells analyzed. 14. Western blot of 4e is not convincing and does not fit to the quantification shown. Please improve and indicate size markers. 15. Was the experiment in figure 5a only performed once? Error bars? 5b a quantification of the increase of the protein levels would be helpful. It would be interesting to know whether the Mdm30 expression levels increased or decreased also after UFA treatment in WT and ubp2Δ cells. 5b and 5d the protein sizes are missing. Significance of 5d (3 vs.4) should be tested. 16. The labelling for Figure 6a is absent (size?, channel?). Figure 6b one time experiment? Error bars? 6c, statistical analysis should be added for significance. 17. Figure 7 , a rescue of the growth defect with a plasmid expressing the protein to verify that the growth defect is specific should be added. Immunoblots with protein size markers are missing (see also remarks above for Figure 7df 
Overview of main changes
New data: 
Point-by-point responses to reviewers' comments

Reviewer #1 (Remarks to the Author):
The manuscript by Cavellini, et al., describes relationships between Ubp2 (a deubiquitinating enzyme), Fzo1 (a mitofusin), and two ubiquitin ligases (Mdm30 and Rsp5). Many of the central conclusions are poorly substantiated and there is a lack of molecular understanding of several of the key observations. Given this, the contribution of the work to the field appears to be minimal. Also, the manuscript is in need of extensive editing. The meaning of several key statements is nearly completely lost due to poor sentence structure and word choice.
Response R1.1: We thank the reviewer for evaluating our manuscript but regret that this summary makes abstraction of the new insights that the study brings on mitochondrial fusion.
Specific comments:
It is unclear why the authors use the word "canonical" when referring to Ubp2 as a "canonical antagonist" of Rsp5. While Ubp2 is an antagonist of Rsp5, their relationship/interaction/mechanism does not follow any general rule and is therefore not canonical of anything. Page 7, first paragraph: an example of the confusion in the writing. It is first said that the "absence of Mdm30 stabilized the mitofusin whether or not UBP2 was also deleted", then two sentences later it is stated that "these results indicate that the accelerated turnover of Fzo1 that is induced by the absence of Ubp2 is abolished in the absence of Mdm30." The first statement is simple and direct, while the second implies some type of regulatory "order" to the system that simply does not exist in either the experiment or in nature. Figure 2a) .
The section on K63 versus K48 chain type specifity of Ubp2 is confusing. The in vitro results are consistent with Ubp2 having very low activity against K48 chains (and perhaps no activity against K48 chains in cells, but this is difficult to know). However, the results are interpreted as being consistent with the fact that Mdm30 catalyzes K48 chain formation on Fzo1. This makes seems to make no sense. The types of chains formed on Fzo1 by Mdm30 must be addressed by determining the type of polyubiquitin chains that are accumulating on Fzo1 in the ubp2 deletion mutant -either by mass spec of the purified protein or perhaps by analysis in a K63R yeast strain. Also, while it is shown that all ubiquitylation of Fzo1 is dependent on K398, I don't see how this bears on the question of chain type. The general issue here is that if Mdm30 is directly ubiquitylating Fzo1 and Ubp2 is directly reversing this reaction, then Mdm30 and Ubp2 are expected to be synthesizing and removing, respectively, the same type of chains. Figure 2b) 
. However, Fzo1 contains 78 lysine residues in its sequence and one can therefore not exclude that chains get added on lysines distinct from K398, on which the Ub doublet is conjugated. The demonstration that all ubiquitylation of Fzo1 is dependent on K398, does not bear on the question of chain type but relates to the confirmation that, in the absence of Ubp2, Ub chains may extend from the doublet conjugated on K398 of Fzo1.
We hope these precisions will help clarifying the conclusions than can be drawn from the dataset shown in Figure 2 .
The section entitled "Upb2 is a physiological substrate for Mdm30-mediated degradation" is underwhelming and incomplete. The changes in Ubp2 levels appear marginal, as does the co-IP of Mdm30 and Ubp2. Also, the types of chains that are accumulating on Ubp2 should again be examined. Are these really K48 chains, as would be expected if catalyzed by Mdm30, or are they K63 chains (perhaps catalyzed by it association with Rsp5). It is unclear whether attempts were made at in vitro reconstitution of the interactions between Mdm30 and Ubp2 and Fzo1, but this is what is clearly needed to get any molecular insight into what is going on here.
Response R1.6: The changes in Ubp2 levels are qualified as marginal but these changes are totally reproducible (seen in Figures 3c, 3d and 3e) and the slow degradation rate of Ubp2 (Figure 3f ) actually explains the only twofold increase of Ubp2 upon stabilization. We are truly sorry that the co-IP between Mdm30 and Ubp2 ( Figure  3d ) is also qualified as marginal. This is a subjective comment to which no rational response can be provided.
We can only reiterate the fact that Ubp2 does co-immunoprecipitate with the F-box mutant of Mdm30 and that the lack of co-IP with WT mdm30 is consistent with the highly transient interactions that usually take place between substrates and E3s, especially when these interactions result in degradation of the substrate. We do not question that analyzing the types of chains conjugated to Ubp2 could be interesting and informative. However, this goes beyond the scope of this already complex study as it is not essential to draw the conclusion that Mdm30 regulates the turnover of Ubp2. Far more important in this matter is the observation that high molecular weight species of Ubp2 decrease in the absence of Mdm30 (Figure 3e).Regarding the in vitro reconstitution of the interactions between Mdm30, Ubp2 and Fzo1, this is unfortunately not feasible at this point because purification of recombinant Fzo1 remains a major roadblock in the field.
Page 11, lines 8-12: The conclusions made in the last two sentences of this paragraph are vague and confusing. "Convey" is a poor word choice -should this be replaced by suggest/imply, or demonstrates/indicates? The last sentence of the paragraph is worse, as I am unclear what the evidence is that Mdm30 affects the myriad activities of Rsp5.
Response R1.7: The word "convey" has been replaced by the word "suggest the last " (Page 12, line15) and sentence of the paragraph has been deleted. Figure 4c (mitochondrial fusion assay): It is entirely unclear why the authors found it surprising that there was total co-localization of fluorophores in the rsp5-delta strain. There are absolutely no controls for this experiment -just one highly engineered experimental strain was examined (rsp5-delta expressing Spt23 "p90").
Response R1.8: Given the pleiotropy of Rsp5 and its established involvement in regulation of mitochondrial homeostasis, we were indeed surprised to find that mitochondrial fusion is not affected in cells lacking Rsp5. The word "surprisingly" has nonetheless been deleted. It is unclear whether qualifying the strain we employed as a highly engineered one must be interpreted as a criticism. The point is that deletion of RSP5 is inviable unless the N-terminal fragment of Spt23 remains expressed in trans. This experiment has been repeated and WT controls have been added (New Figure 4c). In all cases, 100% fusion efficiency was observed indicating that upon maintenance of the OLE1-pathway, mitochondrial fusion remains fully functional in the absence of Rsp5.
Herein, Cavellini and colleagues describe the antagonistic effects of the deubiquitylase enzyme Ubp2 and of the ubiquitin ligase Mdm30 on the mitofusin Fzo1 in yeast and on mitochondrial function. While Ubp2 deletion destabilizes Fzo1, Mdm30 deletion stabilizes it. They then describe an interesting cross talk between the Ole1 pathway of lipid desaturation (in which Ubp2 plays a role) and mitochondrial fission, indicating that Fzo1 levels must be tightly regulated in the face of fluctuations in lipid saturation.
The study is original, unexpected and interesting.
The data are in general of excellent quality and support the most important conclusions of the study. It is a bit unfortunate that the authors did not go as far as testing that the various treatments indeed affect mitochondrial lipid composition as expected, but this is not crucial at this point.
Response R2.1: We thank the reviewer for this accurate overview of the findings presented in the study.
Some additional work and some rewriting could nevertheless improve the manuscript.
Here are the points that need to be adressed experimentally:
-An important conclusion reached by the authors is that Ubp2 antagonizes Mdm30 by directly removing the K48-linked ubiquitins added by Mdm30. To show this, they use a in vitro deubiquitination assay with recombinant Ubp2 and 5x ubiquitin as a substrate. They observe that Ubp2 can remove one ubiquitin and thus conclude that, contrary to previous knowledge, Ubp2 can hydrolyze K48 bonds provided that the chain is at least 5 Ubiquitin long. The specificity of the reaction is not very well controlled: basically the authors rely on the redox sensitivity of Ubp2 to conclude that the cleavage is indeed performed by Ubp2, and not by a contaminating protease. To confirm the "minimum 5 Ub" models, the authors should repeat the experiments of figure 2C with longer UB chains (several groups have use k48-linked hexa-ubiquitin, it should thus be commercially available). This should lead to the appearance of Ub5 and Ub4 species. This is important to show that Ub5 is indeed the limit and that the removal of one ubiquitin from the Ub5 observed here is not simply a spurious phenomenon. -The in vitro fusion assays are very tricky. Mitochondria can stick to each other without fusing. Light microscopy will not make any difference, and lipid composition is likely to affect the stickiness of mitochondria. Mitochondrial fusion is however completely blocked by either GMPPNP or CCCP. It is thus worth adding this control to increase the confidence that what is measured here is indeed fusion and not mere stickiness.
Response R2.4: In in vitro mitochondrial fusion reactions, light microscopy cannot differentiate intermediates that fused their outer membrane from mitochondria that are attached together. This is only true if both the GFP and the mCherry signals emanate from mitochondrial matrices. In our setup, this not the case as GFP is expressed on the outer membrane (OM45-GFP) whereas mCherry lies in the matrix (mito-mCherry). In this context light microscopy clearly differentiates attached mitochondria that appear as proximal GFP-mCherry signals from outer membrane fused intermediates that appear as colocalized GFP-mCherry signals. While this is
with the reviewer that adding actually shown in one of our recent publications (Brandt et al. 2016 -It would be good to have highe exposure panels of all Fzo1 blots, in order to see the ubiquitilated species.
Response R2.5: Fzo1 tagging is essential to detect ubiquitylation of the mitofusin because our anti-Fzo1 is unfortunately not sensitive enough to detect high MW species of the mitofusin. Notably, however, the ubiquitylation status of tagged Fzo1 has been assessed in all mutants and in all conditions used in the study (see in particular new Figure 5c in the presence or in the absence of Oleic Acid treatment) with the exception of mga2 cells (see response R2.10).
Here are some points that need to be soften or rewritten: -Because Mdm30 is needed to observe the polyubiquitylated forms of Fzo1 (that are substrates for Ubp2), the author concludes that Mdm30 is directly responsible for generating them. An alternative model is that Mdm30-mediated K48-linked oligoubiquitzlation of Fzo1 serves as a signal for the recruitment of a yet-unknown E3-ligase that is going to K63-polyubiquitilate Fzo1, thus generating ubiquitin forms that are substrates of Ubp2.
Page 7 of 18
This model is slightly more complicated than that of the authors, but cannot be excluded here. Thus softer wording and acknowledgement of alternative models is required here. -The coIP experiment is not well explained at all. F-box is not defined in the main text. Is interaction only observable with an f-box mutant? What happens with the WT protein? Why are the same panels used in the supplement and the main figure? figure (Figure 3d ) and the full explanation of the figure has been included in the main text (Page 10, line 21 … Page 11, line 6).
Response R2.7: This comment is well taken. We now emphasize that "a non-functional mutant version in the Fbox motif of Mdm30-Myc is unable to bind other SCF components" (Page 10, line 16). We initially placed the whole co-IP figure and its full explanation in supplement to limit the length of the main text. We apologize if this led to loss of information. The partial figure has now been removed and replaced by the whole
-"Since mitochondria are separated from each other in vitro, this spatio-temporal regulation may not be recapitulated, unless Fzo1 levels get increased further". This is a bizarre argument that I cannot understand. Fzo1 levels are naturally increased in oleate-treated yeast. Why should Fzo1 levels be increased further? Mitochndria are not "separated" since they are concentrated by centrifugation. Page 16, .
Response R2.8: We agree that this sentence is difficult to understand and does not really reflect what we initially wanted to express. The main text has now been extensively edited to better relate our line of thoughts (see
-"This specific increase in mitofusin levels upon treatment with UFAs was accompanied by decreased detection of the doublet characteristic of Fzo1 ubiquitylation by Mdm30 ( Fig. 5d ; Fzo1-Ub), which is in agreement with the down-regulation of Mdm30-mediated turnover of Fzo1 by stabilized Ubp2 (Fig. 5b) ." This argument appears to contradict everything that has been said and shown before. Ubp2 stabilization should have no effect whatsoever on the short-Ub chain doublet since Ubp2 is said not to act only on long Ub chains. -The model is that Fzo1 levels are regulated to match lipid instauration levels. In that case deleting Mga2 (thus decreasing insaturation) should lead to decreased Fzo1 levels. Is it the case ? (it may look like it in figure 7G , but that should require repetition and quantification). What is the interpretation if it is not the case? It would be good to see higher exposures of these blots so as to be able to see the ubiquitylated products of Fzo1. (Page 19, .
-In general, many sentences could be simplified. e.g. This study addresses the functional interplay of the deubiquitinase (DUB) Ubp2 with ubiquitin ligases, Mdm30 and Rsp5. In the first part of the manuscript the authors report that Ubp2 acts as an antagonist for Mdm30-mediated turnover of Fzo1 and that Mdm30 targets Ubp2 for degradation. Only the latter represents a truly novel finding. The Mdm30-dependent reduction of Ubp2 levels promotes Rsp5-dependent induction of Ole1-dependent desaturation of fatty acids. Lack of Mdm30 impairs Ole1-dependent synthesis of desaturated fatty acids. Interestingly, desaturated fatty acids impair degradation of Ubp2 and thereby stabilize Fzo1 and promote mitochondrial fusion. This second part of the manuscript thus reports on the novel link between mitochondrial fusion and fatty acid desaturation which, in my eyes, is a main and highly relevant finding. Overall, the manuscript is well written and the conclusions are largely justified.
Response R3.1: Many thanks for this accurate summary.
Still, some experiments are merely confirmatory or have critical problems as they lack important controls or are not clearly explained. Alternative explanations need to be discussed as well. These points need to be resolved before the manuscript is recommended for publication.
Major points:
1. The fact that Ubp2 has an influence on the level/turnover of Fzo1 is already known (Anton et al 2013) . The novelty is more about the antagonism to Mdm30. The confirmatory nature and the novel aspect must be made clearer. Figures 1 and 2 (Page 4, , in the results section (Page 6, Page 7, (8) (9) Page 8, Page 9, Page 10, Page 18, line 15) and in the discussion (Page 21, .
Response R3.2: The reviewer is absolutely correct. We do apologize if this distinction between what was initially found in Anton et al. and our original contributions in
2. The authors show that overexpression of Rsp5 rescues defects caused by lack of Mdm30 and conclude that "accumulation of Ubp2 induces downregulation of Rsp5-mediated functions...". This a possibility but an alternative explanation is that Rsp5 is directly affected by Mdm30. Figure 4a suggests Figure 2b in the revised manuscript). We agree however that this control experiment is absolutely essential to support our conclusions and therefore deserves more emphasis than initially attributed.
Consequently this CHX chase has been repeated and quantified (New supplementary Figure 4b) and demonstrates that Rsp5 turnover is not affected in the absence of Mdm30. The main text has been edited to bring more emphasis on this important control (Page12, line 14).
3. Page 17/18: The rationale for the last part of the results section is not fully clear to me. Why is decreased desaturation and increased turnover of Fzo1 hypothesized to promote fusion? Moreover, the authors state that introduction of an extra copy of Fzo1 induced recue of glycerol growth and tubular mitochondrial morphology in delta ubp2 and double mutants (delta ubp2 delta mga2). Mitochondrial morphology is, however, not recued at all (Fig. 7de) . This needs to be tested statistically to make such a claim. In lines 22/23 the authors mention "increased levels of mitofusins". This is not observed making this conclusion/sentence unclear to me. Figure 7) or to the presence (New Figure 8) 
Response R3.4: We apologize if this last part of the study appeared unclear to the reviewer. A key aspect of this section is the observation that the FZO1 extra copy induces total rescue of glycerol growth in the ubp2 mga2 double mutant but has no effect on the ubp2 single mutant (Figure 8b). This very strong differential effect cannot be attributed to changes in Fzo1 levels or turnover between the two cell types because the absence of Ubp2 induces similarly low levels of Fzo1 whether the FZO1 extra-copy is introduced or not (Figure 8d). In other words, Fzo1 is degraded faster in the absence of Ubp2 and even more Fzo1 molecules are subject to this degradation upon introduction of the FZO1 extra-copy in both single and double mutants. In this context, it is the absence of Mga2 combined with this increased turnover of Fzo1 that allows restauration of respiratory growth in cells that lack Ubp2.Consistent with this, the K398 residue of Fzo1, which is essential for formation of the Mdm30-dependent ubiquitylation doublet (Figure 2e), is also essential for promoting the total rescue of glycerol growth in ubp2 mga2 (data moved from supplementary materials to the main Figure 8e).
We have performed statistical testing on mitochondrial morphology assays. We absolutely agree with the reviewer that mitochondrial morphology in cells that lack Ubp2 is not rescued at all upon deletion of MGA2 (Figure 7d). However, while the introduction of the FZO1-extra copy does not rescue the 15% decrease of tubular mitochondria in the ubp2 single mutant, it does promote total restauration of normal mitochondrial morphology in the ubp2 mga2 double mutant (Figure 8c). This result is thus consistent with those obtained in respiratory growth.
To clarify this section, the former Figure 7 has been split into two distinct Figures according to the absence (New
of the FZO1 extra-copy and the main text has been edited to comment on new experiments added in the revised manuscript (see responses R2.10 and R3.23). The reviewer is otherwise correct about former lines 22/23: "increased levels of mitofusins" has now been replaced by "low levels of mitofusins" (Page 20, line 5).
In general, the authors suggest that the turnover of Fzo1 rather than the level is critical for mitochondrial fusion (and balance of UFAs). The author neglect the possibility that decreased amounts of desaturated fatty acids are the main problem and that Fzo1 may simply need desaturated fatty acids for fusion ( which implies that UFAs are upstream of Fzo1 turnover).
Response R3.5: We thank the reviewer for raising this possibility that Fzo1 may simply require desaturated fatty acids to be active. In this context, mitochondrial fusion should be strongly impaired upon decreased fatty acids desaturation. However, both respiratory growth and mitochondrial morphology remain unaffected upon deletion of MGA2. Moreover, we now show that Fzo1 undergoes faster degradation in mag2 cells (New Figure 8a), which agrees with the notion that Fzo1 turnover facilitates mitochondrial fusion upon low desaturation of fatty acids (see also response R2.10).
4. The authors must improve the clarity and the proper labelling of several figures. Several experiments also lack loading controls and/or statistical testing. For specific points see below.
Minor points:
1. Anton et al 2013 reports on Ubp2-dependent species of ubiquitylated Fzo1 that are low in molecular weight (using expression of an inactive variant of Ubp2). These species are not resolved here (e.g. Fig 2b) . It would be interesting to see whether these species also do depend on Mdm30 (in addition to the "smear" at high MW).
Response R3.6: The reviewer is absolutely correct. Anton et al. detected the accumulation of Fzo1 high MW species in ubp2 cells that migrate below the Mdm30-dependent doublet. These species do not depend on Mdm30 as they persisted in ubp2 mdm30 cells, which led Anton et al. to propose that Ubp2 does not antagonize Mdm30-mediated ubiquitylation of Fzo1. In retrospect, it is therefore likely that two distinct modifications of Fzo1 take place: the Mdm30-dependent and the Mdm30-independent high MW species migrating respectively above and below the characteristic ubiquitylation doublet. Our manuscript rather focuses on the first set, which depends on Mdm30 and that appears corresponding to chains that elongate from the doublet initially conjugated to Lysine 398 of the mitofusin. The second set that does not depend on Mdm30, was described in Anton et al. Investigating its nature and function would require a whole set of further investigations that clearly go above the scope of the present study.
2. The accumulation of high MW ubiquitylated Fzo1 species in delta Ubp2 are not fully convincing. For Fig. 1c (Figure 1b, 1c, 2b, 2e, 5c, supplementary 2c ). This brings, in our view, strong consistency and unequivocal confidence in the existence of these species. In Figure 1c ,
it is the tenuous decrease of Fzo1 high MW species in RSP5 negative (Figure 1c, lanes 2 and 4) as compared to RSP5 positive cells (lanes 1 and 3) that may be misleading. This slight decrease is actually due to the lower levels of Fzo1 in lanes 2 and 4 as compared to lanes 1 and 3. This emphasizes the requirement for normalizing the loading of Fzo1 in order to analyze high MW species of the mitofusin (see response R3.15). In other words, when it comes to analyze the status of Fzo1 ubiquitylation between distinct strains, unmodified Fzo1 is the loading control.
Importantly, the decreased levels of Fzo1 in RSP5 null cells are due to decreased amounts of total proteins in extracts prepared from rsp5 cells. This is illustrated by the ponceau staining that is provided for Reviewer 3 (see accompanying Figure B for reviewers). These decreased amounts of total proteins are likely caused by  cells in liquid media. increased cell death during growth of rsp5
In Figure 1c Figure 1d (Supplementary Figure 1c in the revised manuscript) 6. Page 6 / line 18: Explain better why the expression of Spt23 p90 is needed. The strain must not be labeled as delta strain in the figures as the delta is inviable. (page 6, line 18/19) and in Spt23*). 11. In Figure 2d WT and ubp2Δ Fzo1-Ub banding pattern seems to be different to earlier results (doublet is not clearly seen and high MW species are not enhanced when loading control is taken into account). The immunoblotting is not really convincing. This should be improved. What is the role of K464 residue? Is there an effect in the ubp2Δ strain with K464R, or K398RK464R? Figure 2d (Figure 2e in the revised manuscript) Figure 2e has been enhanced.
Response R3.8: In the original manuscript all error bars in CHX chases corresponded to standard deviations from three independent experiments. In the revised manuscript, these error bars now reflect the standard error of the mean (s.e.m.) for each point, which is actually better adapted for experimental results with a control such as CHX chases. In the particular case of former
Response R3.11: Done in the Figures (rsp5 has been replaced by rsp5 + main text
Response R3.16: In former
Notably, the main purpose of this Figure lies on the observation that ubiquitylation is no longer detected upon mutation of Lysine 398. This indicates that out of the 78 lysine residues of Fzo1, K398 is the main target of Mdm30 for modification of Fzo1 by the Ub doublet. In this context, ubiquitylation of K464 may serve other functions (see response R3.24).
12. (Surma et al. 2013) 
. While not as drastic, the effect of the 25% Ole1 decrease in mdm30 cells may be significant enough to modify lipids on outer membranes and interfere with their fusion. The main text has been edited to emphasize these points (Page 14, lines 3/4 and 8/9).
15. Was the experiment in figure 5a only performed once? Error bars? 5b a quantification of the increase of the protein levels would be helpful. It would be interesting to know whether the Mdm30 expression levels increased or decreased also after UFA treatment in WT and ubp2Δ cells. 5b and 5d the protein sizes are missing. Significance of 5d (3 vs.4) should be tested. Figure 5a has now been repeated. As in Figure 4c , 100% fusion efficiency was obtained in all cases, which exempts any requirement for error bars. In Figure 5b Figure 6c . Statistical significance is now tested in Figure 6c .
Response R3.20: The experiment in
Page 15 of 18 17. Figure 7 , a rescue of the growth defect with a plasmid expressing the protein to verify that the growth defect is specific should be added. Immunoblots with protein size markers are missing (see also remarks above for Figure 7df ). Figure 7a and former Figure 7g (Figure 8d in the revised manuscript) . Remarks on former Figures 7d and 7f have been considered (see response R3.4) .
Response R3.22: The new supplementary Figure 3a demonstrates that the respiratory growth defect of ubp2 cells at 37°C is rescued by WT Ubp2 but not by the catalytic mutant C745S (see response R3.17).Protein size markers have been included in
18. Figure 7b : Why is OLE1 expression reduced in delta Ubp2? Please comment. (Hoppe et al. 2000 and Surma et al. 2013 ). This feedback loop may explain the decrease in OLE1 mRNAs in ubp2 cells. Alternatively, Rsp5 is known to auto-ubiquitylate itself in the absence of Ubp2 (Lam et al. 2013 and New supplementary Figure 4b ), which may decrease its Ub ligase activity thus resulting in down-regulation of the OLE1-pathway. (A) Total protein extracts prepared from WT (MCY554), ubp2Δ (MCY1147), mga2Δ (MCY1078) and ubp2Δ mga2Δ (MCY1098) strains transformed with pRS414-TEF-FZO1-13MYC were analyzed by anti-Myc immunoblotting. MW in kDa are shown on the left of short and long exposures of immunoblots. In this experiment, levels of Fzo1-13Myc were not equalized in UBP2 positive as compared to UBP2 negative extracts. Detection of Fzo1-13Myc higher MW ubiquitylated species in Page 18 of 18 UBP2 negative extracts was consequently hampered. These species were nonetheless present in ubp2Δ and ubp2Δ mga2Δ cells (black arrows above 230 kDa).
Response R3.23: We thank the reviewer for raising this interesting point. Absence of Ubp2 results in loss of Rsp5 antagonism which would be expected to induce over-activation of the OLE1-pathway. Such over-activation is mimicked by addition of unsaturated fatty acids, which generates a feedback control that promotes downregulation of Ole1 synthesis in response to increased desaturation
While the exact reason for down-regulation of the OLE1-pathway in absence of Ubp2 remains to be fully understood, we have now analyzed expression of the Ole1 protein in WT and ubp2 cells (New supplementary Figure 8a). We found that Ole1 only decreases by 5 to 10% in the absence of Ubp2, which does not match the 60% decrease in mRNAs. This discrepancy is nonetheless easily explained by the fact that Mga2 has the ability to stabilize OLE1 mRNAs (Kandasamy et al. 2004). Absence of Ubp2 thus induces down-regulation of the OLE1-
(B) Ponceau staining of yeast extracts from isogenic WT (RSP5) and rsp5 strains. Total amounts of proteins are systematically lower in rsp5 extracts.
(C) [redacted] (D) [redacted]
Reviewers' Comments:
Reviewer #1 (Remarks to the Author) Figure 1: In the experiments related to the rsp5 deletion mutant, kept alive by expressing the p90 fragment of Spt23, the conclusion is that (since Fzo1 levels do not change in this mutant) Rsp5 is not implicated in the regulation of Fzo1 by Ubp2. The problem with this conclusion is that, as the authors are aware, by expressing the p90 fragment of Spt23 you are constitutively leading to the production of presumably high levels of OLE1 and unsaturated fatty acids, which may create a condition that precludes any conclusion about the role of Rsp5 in directly ubiquitylating Fzo1. The authors further substantiate their conclusion by the fact that Fzo1 has been shown to accumulate K48 ubiquitin chains, while Rsp5 catalyzes primarily K63 chains. However, a recent paper provides an explanation for how Rsp5 can lead to the formation of K48 chains (Nature Communications 2016, from T. Mayor's lab). Figure 2C , 2D, Supplementary Figure 2D : I don't understand how any conclusions about Ubp2 biochemical activities can be drawn when the Ubp2 protein that was used for in vitro assays was derived by immunoprecipitation from yeast cells. It is not determined whether Rsp5 or Rup1 (an essential cofactor for Rsp5-Ubp2 interaction) co-IP'd with Ubp2 in these assays and whether these influenced the results of the deubiquitylation assays. This is a major issue and this greatly influences the already speculative conclusions on page 9 of the manuscript (Lines 5-21), which propose that Ubp2 limits Mdm30-catalyzed extension of K48 chains on Fzo1. Figure 3C . There are no error bars or indication of how many biological replicates were employed for this experiment. The effects here are two-fold with respect to levels of Ubp2, so this is critical.
It is not clear why the Mdm30-Ubp2 interaction was not examined more directly, rather than only in co-IPs from cell lysates. The Rsp5-Ubp2 interaction has been recapitulated in vitro, so why not confirm and further characterize the potential interaction with Mdm30 in vitro? This would also allow experiments to be done to determine whether the interaction of Ubp2 with Rup1 (see below) and Rsp5 is mutually exclusive with the Mdm30 interaction.
The results shown in Figures 3e and f are marginal; the difference in half-life of Ubp2 in the absence and presence of Mdm30, in particular. This leads to questioning the conclusion on page 12 lines 1-3: that accumulation of Upb2 via mdm30 deletion leads to the respiratory defect. Figure 43 and f: I don't understand why the same strains were not analyzed for both OLE1 protein and for OLE1 mRNA.
Page 14, lines 18 and 19: the sentence does not make sense and the meaning is unclear.
An important point not brought up by any of the reviewers in the first round of review is that if there really is a ménage a trois between Mdm30 and Ubp2 and Rps5, then there a predicted fourth partner, as well -Rup1 -which is required for Ubp2-Rsp5 interactions. I don't believe Rup1 is never mentioned in the paper.
Reviewer #2 (Remarks to the Author) I am in general satisfied with the author's responses to my points.
The have strengthened their story by providing better evidence of their claims.
-I have one remaining comments/questions concerning the in vitro deubiquitylation assays: no Ub2 K48 species are being generated during the assay, while Ub3 species are strongly increased. The fact that Ub3 are increased argues for Ubp2 being an endo-deubiquitylase. However, since no Ub2 species are generated, this looks more like an exo-ubiquitylase. Is there an explanation for that? In other words: Ub5 can be broken down to Ub4+Ub1 (Fig. 2C ), Ub6 and Ub7 can be broken down to Ub3 (plus something else presumably , Fig 2d) , but Ub2 cannot be generated. This is puzzling and should be discussed.
-An extra effort can still be made on the writing to simplify many sentences.
Reviewer #3 (Remarks to the Author)
The authors have addressed all my concerns sufficiently. The manuscript has improved a lot by the changes and additional experiments and is now recommended for publication.
Minor points: Figure 3d : MW marker is still missing and should be added
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Responses to Reviewers' Comments
To accompany the point-by-point response to Reviewers' comments, below please find an overview of the main changes that have been incorporated into the study.
Overview of main changes
New data: We thank the reviewers for their assessment of our manuscript. We hope that with the new experiments and added clarifications in the revised study, our work will be viewed as suitable for publication in Nature Communications.
Reviewer #1 (Remarks to the Author):
Figure 1: In the experiments related to the rsp5 deletion mutant, kept alive by expressing the p90 fragment of Spt23, the conclusion is that (since Fzo1 levels do not change in this mutant) Rsp5 is not implicated in the regulation of Fzo1 by Ubp2. The problem with this conclusion is that, as the authors are aware, by expressing the p90 fragment of Spt23 you are constitutively leading to the production of presumably high levels of OLE1 and unsaturated fatty acids, which may create a condition that precludes any conclusion about the role of Rsp5 in directly ubiquitylating Fzo1. The authors further substantiate their conclusion by the fact that Fzo1 has been shown to accumulate K48 ubiquitin chains, while Rsp5 catalyzes primarily K63 chains. However, a recent paper provides an explanation for how Rsp5 can lead to the formation of K48 chains (Nature Communications 2016, from T. Mayor's lab). (Kee et al. 2005; Lam et al. 2013; Lam et al. 2009; Ren et al. 2007 ). Figure 1e) or ubiquitylation (New Figure 1f) (Page 7, . Figure 2C , 2D, Supplementary Figure 2D : I don't understand how any conclusions about Ubp2 biochemical activities can be drawn when the Ubp2 protein that was used for in vitro assays was derived by immunoprecipitation from yeast cells. It is not determined whether Rsp5 or Rup1 (an essential cofactor for Rsp5-Ubp2 interaction) co-IP'd with Ubp2 in these assays and whether these influenced the results of the deubiquitylation assays. This is a major issue and this greatly influences the already speculative conclusions on page 9 of the manuscript (Lines 5-21), which propose that Ubp2 limits Mdm30-catalyzed extension of K48 chains on Fzo1. Figure 3C . There are no error bars or indication of how many biological replicates were employed for this experiment. The effects here are two-fold with respect to levels of Ubp2, so this is critical.
Our new observation that the absence of Rup1 does neither impact Fzo1 levels (New
Response R1.3: We agree that this is important. The experiment has been repeated twice more and SD bars (n=3) have been added (New Figure 3c).Our initial observation is confirmed.
It is not clear why the Mdm30-Ubp2 interaction was not examined more directly, rather than only in co-IPs from cell lysates. The Rsp5-Ubp2 interaction has been recapitulated in vitro, so why not confirm and further characterize the potential interaction with Mdm30 in vitro? This would also allow experiments to be done to Page 4 of 9 determine whether the interaction of Ubp2 with Rup1 (see below) and Rsp5 is mutually exclusive with the Mdm30 interaction. Importantly, these findings only suggest that accumulation of Ubp2 via MDM30 deletion could lead to the respiratory defect (Page 12; . The actual demonstration is provided by the fact that deletion of UBP2 or its over-expression, respectively decreases (Figures 3b and supplementary 3b) or enhances (Figures 3g and  supplementary 3f) (Figure 4b) , which phenocopies the effect seen with UBP2 deletion. Figure 43 and f: I don't understand why the same strains were not analyzed for both OLE1 protein and for OLE1 mRNA.
Response R1.6: Regarding 4e, the corresponding mRNA levels were (and are still) An important point not brought up by any of the reviewers in the first round of review is that if there really is a ménage a trois between Mdm30 and Ubp2 and Rps5, then there a predicted fourth partner, as well -Rup1 -which is required for Ubp2-Rsp5 interactions. I don't believe Rup1 is never mentioned in the paper.
Response R1.8: We thank the reviewer for having raised this point. As explained above, we have analyzed the involvement of Rup1 in both the regulation of Fzo1 ubiquitylation/degradation by Ubp2 (Figure 1e, Figure 1f and Figure A for Page 6 of 9 Reviewer #2 (Remarks to the Author):
I am in general satisfied with the author's responses to my points. The have strengthened their story by providing better evidence of their claims.
-I have one remaining comments/questions concerning the in vitro deubiquitylation assays: no Ub2 K48 species are being generated during the assay, while Ub3 species are strongly increased. The fact that Ub3 are increased argues for Ubp2 being an endo-deubiquitylase. However, since no Ub2 species are generated, this looks more like an exo-ubiquitylase. Is there an explanation for that? In other words: Ub5 can be broken down to Ub4+Ub1 (Fig. 2C ), Ub6 and Ub7 can be broken down to Ub3 (plus something else presumably , Fig 2d) , but Ub2 cannot be generated. This is puzzling and should be discussed. Figure 7b has now been included in supplementary Figure 8a) . The text corresponding to the description of this figure has also been moved from the main text to the legend of supplementary figure 8a. We hope that with these changes, the manuscript reads now better and is suitable for publication.
